Advanced Filters
noise
Found 300 clinical trials
V Victoria E Banuchi, MD

Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules

To observe the outcomes of nsPFA therapy to treat benign thyroid nodules.

18 years of age All Phase N/A
E Ethics Committee

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

This is a multicenter, open-label extension (OLE) study of MHB018A in subjects with moderate-to-severe TED.

18 - 75 years of age All Phase 3
y yan li, B.S

Health-Related Quality of Life and Emotions in Patients with Thyroid Nodules

The purpose of this observational research is to evaluate and compare the health-related quality of life and emotional well-being of patients with thyroid nodules before and after treatment. This is a data collection study by allowing investigators to access information generated before and after treatment.

18 - 70 years of age All Phase N/A
J Jennifer H Kuo, MD MS

RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study

The purpose of this observational research is to evaluate and compare clinical outcomes after treatment for symptomatic benign multinodular goiter (MNG) patients. This is a data collection study in which we ask participants to give access to information generated before and after treatment of their condition.

18 years of age All Phase N/A
S Sohag University Hospital Sohag

Assessment of Thyroid Dysfunction in Patients Undergoing Haemodialysis at Sohag University Hospital

Thyroid dysfunction is a prevalent endocrine disorder that significantly impacts the health of patients with chronic kidney disease (CKD), particularly those undergoing dialysis. The prevalence of thyroid dysfunction in dialysis patients has been reported to range from 20% to 60%, highlighting the need for routine screening and management in this …

13 - 80 years of age All Phase N/A
M Man Him, Matrix Fung, MBBS

MWA vs RFA for the Treatment of Moderate-sized Benign Thyroid Nodules

Thyroid nodule is a common condition that affects up to 60% of the population. There is an estimated 10% lifetime probability of developing a thyroid nodule. Although most thyroid nodules are benign, up to 10-15% can enlarge to cause compressive symptoms including neck pressure and discomfort, dysphagia, dyspnea, and dysphonia. …

18 years of age All Phase N/A
S Shimaa A Meshaal, MD

Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease

This study aims to evaluate the prevalence of thyroid dysfunction and its association with metabolic dysfunction-associated fatty liver disease.

18 years of age All Phase N/A
h huifang zhou, Doctor

A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease

This is a multicenter, randomized, open-label, active-controlled Phase IV clinical trial in participants with active thyroid eye disease (TED). Approximately 92 eligible participants will be randomized to the teprotumumab N01 group and the intravenous glucocorticoid (IVGC) group in a 1:1 ratio on Day 1. The randomization stratification factor is diplopia …

18 - 80 years of age All Phase 4
V VP, Medical Affairs

A Study of VV-14305 for the Treatment of Thyroid Eye Disease

The goal of this study is to evaluate the safety, tolerability, and efficacy of KRIYA-586 (VV-14305) in treating thyroid eye disease (TED).

18 - 80 years of age All Phase 1/2

Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules

A multicenter, prospective, randomized, double-blind, placebo-controlled clinical trial was designed to evaluate the efficacy and safety of Prunella oral liquid in patients with benign thyroid nodules, which belongs to the post-marketing reevaluation clinical study. In this study, 234 subjects will be enrolled by competitive enrollment at several research centers across …

18 - 65 years of age All Phase 4

Simplify language using AI